Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Pfizer stock dips after Xeljanz lands on Medicare price-talk list, with earnings looming

Pfizer stock dips after Xeljanz lands on Medicare price-talk list, with earnings looming

Pfizer shares were down 1.7% at $26.06 in late morning trade on Wednesday after the U.S. Centers for Medicare & Medicaid Services added its arthritis drug Xeljanz to the next round of Medicare drug price negotiations. CMS said the talks will run in 2026, with negotiated prices slated to take effect on Jan. 1, 2028, and companies facing a Feb. 28 deadline to sign participation agreements.
28 January 2026
···
Why TEN Holdings stock is moving: XHLD slides premarket after 177% jump

Why TEN Holdings stock is moving: XHLD slides premarket after 177% jump

Shares of TEN Holdings, Inc dropped roughly 33% to $2.36 in premarket trading by 8:49 a.m. ET Wednesday, following a huge 177% surge to $3.52 on Tuesday. Volume spiked to about 139 million shares that day, dwarfing the three-month average of around 3.2 million. Over the past year, the stock's price has ranged from a low of $1.05 to a high of $128.10, per Investing.com.
28 January 2026
·
1 … 154 155 156 157 158 … 609
Follow on Google News
Add as preferred source Open in Google News